Vanguard Group »

Enliven Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $43M 1.8M 23.37
2024-03-31 $21M 1.2M 17.59
2023-12-31 $17M 1.2M 13.84
2023-09-30 $16M 1.2M 13.66
2023-06-30 $23M 1.1M 20.41
2023-03-31 $3.3M 152k 21.90